Broadfin Capital’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $15.6M | Buy |
|
|||||
|
2019
Q3 | $8.01M | Buy |
|
|||||
|
2018
Q2 | – | Hold |
|
|||||
|
2018
Q1 | – | Hold |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $6.79M | Sell |
|
|||||
|
2017
Q1 | $18.9M | Sell |
|
|||||
|
2016
Q4 | $77.3M | Hold |
|
|||||
|
2016
Q3 | $56.7M | Hold |
|
|||||
|
2016
Q2 | $37.8M | Hold |
|
|||||
|
2016
Q1 | $39M | Hold |
|
|||||
|
2015
Q4 | $54.9M | Hold |
|
|||||
|
2015
Q3 | $51.2M | Hold |
|
|||||
|
2015
Q2 | $66.8M | Hold |
|
|||||
|
2015
Q1 | $53.5M | Hold |
|
|||||
|
2014
Q4 | $67.7M | Hold |
|
|||||
|
2014
Q3 | $46.5M | Buy |
|
|||||
|
2014
Q2 | $28.6M | Buy |
|
|||||
|
2014
Q1 | $22.8M | Buy |
|
|||||
|
2013
Q4 | $21.3M | Buy |
|
|||||
|
2013
Q3 | $17.5M | Sell |
|
|||||
|
2013
Q2 | $15.6M | Buy |
|